170 related articles for article (PubMed ID: 22860185)
1. Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors.
Tisch U; Aluf Y; Ionescu R; Nakhleh M; Bassal R; Axelrod N; Robertman D; Tessler Y; Finberg JP; Haick H
ACS Chem Neurosci; 2012 Mar; 3(3):161-6. PubMed ID: 22860185
[TBL] [Abstract][Full Text] [Related]
2. Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors.
Tisch U; Schlesinger I; Ionescu R; Nassar M; Axelrod N; Robertman D; Tessler Y; Azar F; Marmur A; Aharon-Peretz J; Haick H
Nanomedicine (Lond); 2013 Jan; 8(1):43-56. PubMed ID: 23067372
[TBL] [Abstract][Full Text] [Related]
3. Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes.
Ionescu R; Broza Y; Shaltieli H; Sadeh D; Zilberman Y; Feng X; Glass-Marmor L; Lejbkowicz I; Müllen K; Miller A; Haick H
ACS Chem Neurosci; 2011 Dec; 2(12):687-93. PubMed ID: 22860162
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath analysis with electronic nose technology for detection of acute liver failure in rats.
Wlodzimirow KA; Abu-Hanna A; Schultz MJ; Maas MA; Bos LD; Sterk PJ; Knobel HH; Soers RJ; Chamuleau RA
Biosens Bioelectron; 2014 Mar; 53():129-34. PubMed ID: 24135544
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone Attenuates Neuroinflammation and Promotes Dopaminergic Neuronal Survival in the Nigrostriatal System of Rats after Diffuse Brain Injury.
Liu M; Bachstetter AD; Cass WA; Lifshitz J; Bing G
J Neurotrauma; 2017 Jan; 34(2):414-422. PubMed ID: 27142118
[TBL] [Abstract][Full Text] [Related]
6. Altered Volatile Organic Compound Profile in Transgenic Rats Bearing A53T Mutation of Human α-Synuclein: Comparison with Dopaminergic and Serotonergic Denervation.
Finberg JPM; Aluf Y; Loboda Y; Nakhleh MK; Jeries R; Abud-Hawa M; Zubedat S; Avital A; Khatib S; Vaya J; Haick H
ACS Chem Neurosci; 2018 Feb; 9(2):291-297. PubMed ID: 29017011
[TBL] [Abstract][Full Text] [Related]
7. Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy.
Engeln M; Ansquer S; Dugast E; Bezard E; Belin D; Fernagut PO
Neuropharmacology; 2016 Oct; 109():69-77. PubMed ID: 27216859
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Exhaled Breath Samples from Patients with Alzheimer's Disease Using Gas Chromatography-Mass Spectrometry and an Exhaled Breath Sensor System.
Lau HC; Yu JB; Lee HW; Huh JS; Lim JO
Sensors (Basel); 2017 Aug; 17(8):. PubMed ID: 28771180
[TBL] [Abstract][Full Text] [Related]
9. Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?
De Luca MA; Cauli O; Morelli M; Simola N
J Neurochem; 2014 Nov; 131(3):284-9. PubMed ID: 24989117
[TBL] [Abstract][Full Text] [Related]
10. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
11. Electrochemical sensor system for breath analysis of aldehydes, CO and NO.
Obermeier J; Trefz P; Wex K; Sabel B; Schubert JK; Miekisch W
J Breath Res; 2015 Mar; 9(1):016008. PubMed ID: 25749754
[TBL] [Abstract][Full Text] [Related]
12. Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease.
Struzyna LA; Browne KD; Brodnik ZD; Burrell JC; Harris JP; Chen HI; Wolf JA; Panzer KV; Lim J; Duda JE; España RA; Cullen DK
J Tissue Eng Regen Med; 2018 Jul; 12(7):1702-1716. PubMed ID: 29766664
[TBL] [Abstract][Full Text] [Related]
13. Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson's disease via suppression of LASP1.
Ma X; Zhang H; Yin H; Geng S; Liu Y; Liu C; Zhao J; Liu Y; Wang X; Wang Y
Brain Res Bull; 2021 Jan; 166():92-101. PubMed ID: 33144090
[TBL] [Abstract][Full Text] [Related]
14. Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease.
Sun Y; Lu XJ; Fu X; Zhang Y; Zhan Y; Liu J; Zhao L; Xia CL
Mol Cell Biochem; 2021 Feb; 476(2):619-631. PubMed ID: 33070275
[TBL] [Abstract][Full Text] [Related]
15. Altered melatonin MT
Kang NH; Carriere CH; Bahna SG; Niles LP
Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
[TBL] [Abstract][Full Text] [Related]
16. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure.
Agim ZS; Cannon JR
Toxicol Lett; 2018 May; 287():31-41. PubMed ID: 29378243
[TBL] [Abstract][Full Text] [Related]
18. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
19. Volatile organic compounds during inflammation and sepsis in rats: a potential breath test using ion-mobility spectrometry.
Fink T; Wolf A; Maurer F; Albrecht FW; Heim N; Wolf B; Hauschild AC; Bödeker B; Baumbach JI; Volk T; Sessler DI; Kreuer S
Anesthesiology; 2015 Jan; 122(1):117-26. PubMed ID: 25170570
[TBL] [Abstract][Full Text] [Related]
20. Modeling nigrostriatal degeneration in organotypic cultures, a new ex vivo model of Parkinson's disease.
Daviaud N; Garbayo E; Lautram N; Franconi F; Lemaire L; Perez-Pinzon M; Montero-Menei CN
Neuroscience; 2014 Jan; 256():10-22. PubMed ID: 24161279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
